Anti-FAIM2 monoclonal antibody

Pre-made anti-FAIM2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAIM2/FAIM2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0790-Ab-1/ GM-Tg-hg-IP0790-Ab-2Anti-Human FAIM2 monoclonal antibodyHuman
GM-Tg-rg-IP0790-Ab-1/ GM-Tg-rg-IP0790-Ab-2Anti-Rat FAIM2 monoclonal antibodyRat
GM-Tg-mg-IP0790-Ab-1/ GM-Tg-mg-IP0790-Ab-2Anti-Mouse FAIM2 monoclonal antibodyMouse
GM-Tg-cynog-IP0790-Ab-1/ GM-Tg-cynog-IP0790-Ab-2Anti-Cynomolgus/ Rhesus macaque FAIM2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0790-Ab-1/ GM-Tg-felg-IP0790-Ab-2Anti-Feline FAIM2 monoclonal antibodyFeline
GM-Tg-cang-IP0790-Ab-1/ GM-Tg-cang-IP0790-Ab-2Anti-Canine FAIM2 monoclonal antibodyCanine
GM-Tg-bovg-IP0790-Ab-1/ GM-Tg-bovg-IP0790-Ab-2Anti-Bovine FAIM2 monoclonal antibodyBovine
GM-Tg-equg-IP0790-Ab-1/ GM-Tg-equg-IP0790-Ab-2Anti-Equine FAIM2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0790-Ab-1/ GM-Tg-hg-IP0790-Ab-2; GM-Tg-rg-IP0790-Ab-1/ GM-Tg-rg-IP0790-Ab-2;
GM-Tg-mg-IP0790-Ab-1/ GM-Tg-mg-IP0790-Ab-2; GM-Tg-cynog-IP0790-Ab-1/ GM-Tg-cynog-IP0790-Ab-2;
GM-Tg-felg-IP0790-Ab-1/ GM-Tg-felg-IP0790-Ab-2; GM-Tg-cang-IP0790-Ab-1/ GM-Tg-cang-IP0790-Ab-2;
GM-Tg-bovg-IP0790-Ab-1/ GM-Tg-bovg-IP0790-Ab-2; GM-Tg-equg-IP0790-Ab-1/ GM-Tg-equg-IP0790-Ab-2
Products NameAnti-FAIM2 monoclonal antibody
Formatmab
Target NameFAIM2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAIM2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0790-Ag-1Recombinant multi-species LFG2/ FAIM2/ LFG protein
    ORF Viral VectorvGMLP000083human FAIM2 Lentivirus particle
    ORF Viral VectorpGMLP000083human FAIM2 Lentivirus plasmid
    ORF Viral VectorpGMLPm001002mouse Faim2 Lentivirus plasmid
    ORF Viral VectorvGMLPm001002mouse Faim2 Lentivirus particle


    Target information

    Target IDGM-IP0790
    Target NameFAIM2
    Gene ID23017,72393,246274,711631,477613,101085220,509790,100052142
    Gene Symbol and Synonyms2900002L20Rik,FAIM2,LFG,LFG2,NGP35,NMP25,NMP35,™BIM2
    Uniprot AccessionQ9BWQ8,O88407,Q1LZ71
    Uniprot Entry NameLFG2_HUMAN,LFG2_RAT,LFG2_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseProstate Cancer
    Gene EnsemblENSG00000135472
    Target ClassificationN/A

    The target: FAIM2, gene name: FAIM2, also named as LFG, LFG2, NGP35, NMP35, ™BIM2. Involved in regulation of neuron apoptotic process. Acts upstream of or within negative regulation of extrinsic apoptotic signaling pathway via death domain receptors. Located in membrane raft. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.